Developing and testing a system to improve the quality of heparin anticoagulation in patients with acute cardiac syndromes
- 1 September 1998
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 82 (5) , 574-579
- https://doi.org/10.1016/s0002-9149(98)00405-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Activated Partial Thromboplastin Time and Outcome After Thrombolytic Therapy for Acute Myocardial InfarctionCirculation, 1996
- Hemorrhagic Complications of Anticoagulant TreatmentChest, 1995
- Use of a Standardized Heparin Nomogram to Achieve Therapeutic Anticoagulation After Thrombolytic Therapy in Myocardial InfarctionArchives of internal medicine (1960), 1994
- Establishing a Therapeutic Range for Heparin TherapyAnnals of Internal Medicine, 1993
- A Comparison between Heparin and Low-Dose Aspirin as Adjunctive Therapy with Tissue Plasminogen Activator for Acute Myocardial InfarctionNew England Journal of Medicine, 1990
- A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapyThe American Journal of Medicine, 1990
- Bayesian Forecasting of APTT Response to Continuously Infused Heparin with and Without Warfarin AdministrationThe Journal of Clinical Pharmacology, 1989
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986
- Heparin therapy: A randomized prospective studyAmerican Heart Journal, 1979
- Heparin kinetics in venous thrombosis and pulmonary embolism.Circulation, 1976